Extended Rhythm SCreening for AtRial Fibrillation in Cryptogenic Stroke Patients "SCARF"

Active, not recruiting

Phase N/A Results N/A

Update History

8 Jul '16
The eligibility criteria were updated.
New
Inclusion Criteria: - Patients > 18 years of age Recent episode (≤60 days) of cryptogenic ischemic stroke - Undetermined etiology with negative evaluation (including cardioembolism work- up) according to the criteria for the Trial of Org 10172 in Acute Stroke Treatment (TOAST) - Implantation of an implantable loop recorder within two months after index event - Able of providing informed consent Exclusion Criteria: - Pre-existing indication for vitamin K antagonist - Untreated hyperthyroidism - Indication for pacemaker implantation, implantable cardioverter defibrillator (ICD) or Cardiac Resynchronisation Therapy (CRT) - Severe co-morbidity not likely to complete follow-up for one year
Old
Inclusion Criteria: - Patients > 18 years of age Recent episode (≤60 days) of cryptogenic ischemic stroke - Undetermined etiology with negative evaluation (including cardioembolism work- up) according to the criteria for the Trial of Org 10172 in Acute Stroke Treatment (TOAST) - Implantation of an implantable loop recorder within two months after index event - Able of providing informed consent Exclusion Criteria: - Pre-existing indication for vitamin K antagonist - Untreated hyperthyroidism - Indication for pacemaker implantation, implantable cardioverter defibrillator (ICD) or Cardiac Resynchronisation Therapy (CRT) - Severe co-morbidity not likely to complete follow-up for one year
A location was updated in Enschede.
New
The overall status was removed for Medisch Spectrum Twente / Thoraxcenter.
24 Apr '12
The eligibility criteria were updated.
New
Inclusion Criteria: - Patients > 18 years of age Recent episode (≤60 days) of cryptogenic ischemic stroke - Undetermined etiology with negative evaluation (including cardioembolism work- up) according to the criteria for the Trial of Org 10172 in Acute Stroke Treatment (TOAST) - Implantation of an implantable loop recorder within two months after index event - Able of providing informed consent Exclusion Criteria: - Pre-existing indication for vitamin K antagonist - Untreated hyperthyroidism - Indication for pacemaker implantation, implantable cardioverter defibrillator (ICD) or Cardiac Resynchronisation Therapy (CRT) - Severe co-morbidity not likely to complete follow-up for one year
Old
Inclusion Criteria: - Patients > 18 years of age Recent episode (≤60 days) of cryptogenic ischemic stroke - Undetermined etiology with negative evaluation (including cardioembolism work- up) according to the TOAST criteria - Implantation of an implantable loop recorder within two months after index event - Able of providing informed consent Exclusion Criteria: - Pre-existing indication for vitamin K antagonist - Untreated hyperthyroidism - Indication for pacemaker implantation, ICD or CRT device - Severe co-morbidity not likely to complete follow-up for one year